---
title: "Gerresheimer Divests Plastic Packaging Units to Apax Funds for €1.5 Billion"
url: https://projectchintan.com/article/gerresheimer-divests-plastic-packaging-units-to-apax-funds-for-1-5-billion-6xz68
publisher: Project Chintan
author: Project Chintan Newsroom
published: 2026-07-31T05:00:00.000Z
modified: 2026-07-31T08:02:16.907Z
language: en-IN
---

# Gerresheimer Divests Plastic Packaging Units to Apax Funds for €1.5 Billion

Gerresheimer is selling its Centor and Primary Packaging Plastics divisions to Apax Funds to prioritize high-margin drug delivery systems. The deal covers 16 global production sites and follows a portfolio optimization strategy.

## Key takeaways

- Apax Funds will acquire Gerresheimer's Centor and Primary Packaging Plastics divisions for approximately €1.5 billion.
- The divested business units generated a combined revenue of €570 million in 2025 and employ 2,400 workers across nine countries.
- Gerresheimer will use the proceeds to reduce corporate debt and invest in high-margin pharmaceutical drug delivery systems.
- The Centor transaction expects a 2026 completion, while the Primary Packaging Plastics sale should finalize in the first half of 2027.

## Strategic Pivot Toward Specialized Medical Devices

Gerresheimer has reached an agreement to divest its global Primary Packaging Plastics (PPP) division and its Centor business to Apax Funds. The deal, valued at roughly €1.5 billion, marks a significant shift in corporate strategy. By offloading these assets, the company intends to concentrate resources on its pharmaceutical drug delivery and medical device portfolios. Management plans to utilize the capital from this sale to pay down debt and solidify the balance sheet while funding a transition into higher-value technology sectors.

### Financial Performance and Operational Scope

The assets involved in this transaction represent a substantial portion of current operations, including 16 facilities located across nine different nations. Approximately 2,400 employees will transfer with the business units. In 2025, the combined revenue of Centor and the PPP division reached nearly €570 million. Centor currently holds a prominent position within the United States market as a supplier of systems for dispensing prescription drugs.

### Phased Exit Strategy and Regulatory Timeline

The divestiture will occur in stages rather than a single event. - Centor is slated for off-sale completion by the conclusion of the 2026 financial year. - The Primary Packaging Plastics division is projected to finalize its transfer during the first half of the 2027 financial year. Each phase of the transaction depends on regular closing conditions and the acquisition of necessary regulatory clearances. This move mirrors a broader trend within the healthcare sector where suppliers are increasingly shedding basic packaging lines to pursue specialized, technology-driven assets that offer superior margins.

Source: Global Cosmetics News

---
Canonical: https://projectchintan.com/article/gerresheimer-divests-plastic-packaging-units-to-apax-funds-for-1-5-billion-6xz68
Reported from: Global Cosmetics News